Edwards Lifesciences Corporation Cash and Cash Equivalents, Period Increase (Decrease)
Edwards Lifesciences Corporation (EW) reported Cash and Cash Equivalents, Period Increase (Decrease) of $472.50 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-25.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-10-25
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $459.80M, a 1217.48% increase year-over-year.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $17.60M.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$4.90M, a 101.20% decline year-over-year.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$547.20M, a 391.06% decline year-over-year.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$104.20M.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$111.80M, a 152.81% decline from fiscal 2016.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for fiscal 2016 was $211.70M, a 227.71% increase from fiscal 2015.
- Edwards Lifesciences Corporation cash and cash equivalents, period increase (decrease) for fiscal 2015 was $64.60M, a 72.32% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $459.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $477.40M derived: sum of 2 quarters · filed 2019-10-25 | $472.50M 10-Q · filed 2019-10-25 | -$74.70M derived: sum of 4 quarters · filed 2019-10-25 |
| 2019-06-30 | $17.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $12.70M 10-Q · filed 2019-07-26 | -$534.50M derived: sum of 3 quarters · filed 2019-07-26 | -$499.60M derived: sum of 4 quarters · filed 2019-10-25 |
| 2019-03-31 | -$4.90M 10-Q · filed 2019-04-26 | -$552.10M derived: sum of 2 quarters · filed 2019-04-26 | -$517.20M derived: sum of 3 quarters · filed 2019-10-25 | -$517.80M derived: sum of 4 quarters · filed 2019-10-25 |
| 2018-12-31 | -$547.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$512.30M derived: sum of 2 quarters · filed 2019-10-25 | -$512.90M derived: sum of 3 quarters · filed 2019-10-25 | -$104.20M 10-K · filed 2019-02-15 |
| 2018-09-30 | $34.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $34.30M derived: sum of 2 quarters · filed 2019-10-25 | $443.00M 10-Q · filed 2019-10-25 | $631.00M derived: sum of 4 quarters · filed 2019-10-25 |
| 2018-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $408.10M 10-Q · filed 2019-07-26 | $596.10M derived: sum of 3 quarters · filed 2019-07-26 | $718.20M derived: sum of 4 quarters · filed 2019-07-26 |
| 2018-03-31 | $408.70M 10-Q · filed 2019-04-26 | $596.70M derived: sum of 2 quarters · filed 2019-04-26 | $718.80M derived: sum of 3 quarters · filed 2019-04-26 | $407.70M derived: sum of 4 quarters · filed 2019-04-26 |
| 2017-12-31 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $310.10M derived: sum of 2 quarters · filed 2019-02-15 | -$1.00M derived: sum of 3 quarters · filed 2019-02-15 | -$111.80M 10-K · filed 2019-02-15 |
| 2017-09-30 | $122.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$189.00M derived: sum of 2 quarters · filed 2018-10-26 | -$299.80M 10-Q · filed 2018-10-26 | -$14.70M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$311.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$421.90M 10-Q · filed 2018-07-27 | -$136.80M derived: sum of 3 quarters · filed 2019-02-15 | $138.30M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | -$110.80M 10-Q · filed 2018-04-27 | $174.30M derived: sum of 2 quarters · filed 2019-02-15 | $449.40M derived: sum of 3 quarters · filed 2019-02-15 | $317.90M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $285.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $560.20M derived: sum of 2 quarters · filed 2019-02-15 | $428.70M derived: sum of 3 quarters · filed 2019-02-15 | $211.70M 10-K · filed 2019-02-15 |
| 2016-09-30 | $275.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $143.60M derived: sum of 2 quarters · filed 2017-10-27 | -$73.40M 10-Q · filed 2017-10-27 | -$1.10M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$131.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$348.50M 10-Q · filed 2017-07-28 | -$276.20M derived: sum of 3 quarters · filed 2018-02-16 | -$227.70M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$217.00M 10-Q · filed 2017-04-28 | -$144.70M derived: sum of 2 quarters · filed 2018-02-16 | -$96.20M derived: sum of 3 quarters · filed 2018-02-16 | $44.40M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $72.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $120.80M derived: sum of 2 quarters · filed 2018-02-16 | $261.40M derived: sum of 3 quarters · filed 2018-02-16 | $64.60M 10-K · filed 2018-02-16 |
| 2015-09-30 | $48.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $189.10M derived: sum of 2 quarters · filed 2016-10-28 | -$7.70M 10-Q · filed 2016-10-28 | $242.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $140.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$56.20M 10-Q · filed 2016-07-29 | $193.50M derived: sum of 3 quarters · filed 2017-02-17 | $99.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$196.80M 10-Q · filed 2016-04-29 | $52.90M derived: sum of 2 quarters · filed 2017-02-17 | -$41.60M derived: sum of 3 quarters · filed 2017-02-17 | $161.30M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $249.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $155.20M derived: sum of 2 quarters · filed 2017-02-17 | $358.10M derived: sum of 3 quarters · filed 2017-02-17 | $233.40M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$94.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $108.40M derived: sum of 2 quarters · filed 2015-10-29 | -$16.30M 10-Q · filed 2015-10-29 | -$66.90M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $202.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $78.20M 10-Q · filed 2015-07-29 | $27.60M derived: sum of 3 quarters · filed 2016-02-19 | $125.90M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$124.70M 10-Q · filed 2015-04-29 | -$175.30M derived: sum of 2 quarters · filed 2016-02-19 | -$77.00M derived: sum of 3 quarters · filed 2016-02-19 | -$105.80M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$50.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $47.70M derived: sum of 2 quarters · filed 2016-02-19 | $18.90M derived: sum of 3 quarters · filed 2016-02-19 | $109.50M 10-K · filed 2016-02-19 |
| 2013-09-30 | $98.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $69.50M derived: sum of 2 quarters · filed 2014-10-31 | $160.10M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | -$28.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $61.80M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $90.60M 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | $139.70M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | -$224.90M 10-K · filed 2014-02-28 | |||
| 2011-06-30 | $34.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $72.10M 10-Q · filed 2011-08-08 | $107.20M derived: sum of 3 quarters · filed 2011-08-08 | $147.90M derived: sum of 4 quarters · filed 2011-08-08 |
| 2011-03-31 | $37.70M 10-Q · filed 2011-05-09 | $72.80M derived: sum of 2 quarters · filed 2011-05-09 | $113.50M derived: sum of 3 quarters · filed 2011-05-09 | $112.60M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-12-31 | $35.10M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $75.80M derived: sum of 2 quarters · filed 2011-02-28 | $74.90M derived: sum of 3 quarters · filed 2011-08-08 | $62.00M 10-K · filed 2011-02-28 |
| 2010-09-30 | $40.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $39.80M derived: sum of 2 quarters · filed 2011-08-08 | $26.90M 10-Q · filed 2010-11-08 | $73.40M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-06-30 | -$900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$13.80M 10-Q · filed 2011-08-08 | $32.70M derived: sum of 3 quarters · filed 2011-08-08 | $137.20M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-03-31 | -$12.90M 10-Q · filed 2011-05-09 | $33.60M derived: sum of 2 quarters · filed 2011-05-09 | $138.10M derived: sum of 3 quarters · filed 2011-05-09 | |
| 2009-12-31 | $46.50M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $151.00M derived: sum of 2 quarters · filed 2011-02-28 | $115.40M 10-K · filed 2011-02-28 | |
| 2009-09-30 | $104.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $68.90M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | -$35.60M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $76.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |